EnvisionOne Vantage enables medical affairs professionals to benchmark their publication performance against other companies, providing crucial competitive intelligence and valuable insights for strategic adjustments to publication strategies.
Read MoreAdnexus Biotechnologies Inc. is at the forefront of the battle against malaria by developing Trapicolast, an antimalarial medication created through the innovative Sutra™ AI platform. This advancement exemplifies the transformative potential of artificial intelligence in revolutionizing the drug discovery process.
Read More54% of patients experience more than 2.5 years of durable hematocrit (Hct) control (<45%), decreased phlebotomy use, long-term tolerability, and improvements in patient-reported outcomes in patients with polycythemia vera
Read MoreOral peptide with biologics-like high potency and spectrum of activity against three therapeutically relevant dimeric forms of IL-17 (AA, AF and FF)
IND enabling studies underway, with Phase I initiation expected in Q425
Webcast and conference call to be held today at 4:30 pm ET
Read More